Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986830 · ClinicalTrials.gov registry record · NA
Healthcare Utilization and Outcomes of FinESS Treatment in the Office
A NA study, sponsored by Entellus Medical.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT00986830: Completed NA study, sponsored by Entellus Medical.
NCT00986830 is a NA study that has completed, run by Entellus Medical. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986830, a NA study, has completed, sponsored by Entellus Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
A prospective, nonrandomized trial to evaluate postoperative healthcare resource utilization after maxillary balloon antrostomy using FinESS Sinus Treatment in the physician's office.
Primary Outcome
The 20-item Sino-Nasal Outcomes Test (SNOT-20) is a validated, disease-specific patient-reported instrument designed to indicate the severity of rhinosinusitis symptoms. The SNOT-20 evaluates 20 symptoms on a scale from 0 ("no problem") to 5 ("problem as bad as it can be"). The overall SNOT-20 score is the average of the 20 symptoms scores providing a range from 0 to 5 with higher scores indicating worse symptoms. The minimal clinically important difference (MCID) has been determined to be a red
Interventions
- DEVICE FinESS Sinus Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00986830 record still lists
NCT00986830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which FinESS Sinus Treatment is the first listed.
NCT00986830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986830 about?
NCT00986830 is a clinical study titled "Healthcare Utilization and Outcomes of FinESS Treatment in the Office". A prospective, nonrandomized trial to evaluate postoperative healthcare resource utilization after maxillary balloon antrostomy using FinESS Sinus Treatment in the physician's office.
What is the current status of trial NCT00986830?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2009-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00986830?
The interventions under investigation include: FinESS Sinus Treatment (DEVICE).
Who is sponsoring clinical trial NCT00986830?
This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00986830's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia